{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:06:55Z","timestamp":1772168815642,"version":"3.50.1"},"reference-count":28,"publisher":"BMJ","issue":"9","funder":[{"name":"Optimed GmbH, Ettlingen, Germany"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,7,28]]},"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Deep venous obstruction (DVO) has a great impact on quality of life (QoL) comparable to angina pectoris or chronic pulmonary disease. Post-thrombotic scar formation and May-Thurner syndrome (MTS) are the most common causes of DVO. Conventional treatment of DVO focuses on reducing pain or leg swelling by use of (pain) medication and therapeutic elastic stockings. In the past, a venous bypass was offered in severe post-thrombotic cases, but this procedure showed bad clinical and patency outcomes. With the introduction of percutaneous angioplasty and dedicated venous stents new opportunities were created. Deep venous stenting has been shown to be effective in retrospective case series. However, there is no prior research in which QoL after interventional treatment is compared with QoL after conventional treatment. Currently, there is a debate about the true additional value of interventional treatment. We investigate whether those patients who are treated with stenting experience a change in short form 36 (SF-36) and the Veines-QoL\/Sym questionnaires compared with conventionally treated patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a randomised trial comparing conservative deep venous management to interventional treatment. A total of 130 patients with post-thrombotic syndrome (PTS) or MTS, eligible for interventional percutaneous treatment, who did not have previous deep venous intervention will be included. Patients will be randomised to conservative treatment or venous stenting and stratified for the PTS or MTS subgroup. Conservative treatment consists of either one or a combination of pain medications, manual lymphatic drainage, compression stockings and regular post-thrombotic anticoagulant therapy.<\/jats:p>\n                    <jats:p>The primary outcome is the QoL change after 12 months compared with baseline QoL. Secondary outcomes are QoL changes at 6 weeks, clinical assessment of DVO, recurrence rate of deep venous thrombosis at 6 weeks and 12 months, and the total amount of working days lost. Intervention-specific outcomes include complications and patency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The protocol is approved by the Medical Ethics Committee of Academisch ziekenhuis Maastricht\/Universiteit Maastricht, The Netherlands (protocol number NLNL55641.068.15 \/ METC 161008).We aim to publish the results of this study in a peer reviewed journal and present our findings at national or international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      The study protocol was registered at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"www.clinicaltrials.gov\" ext-link-type=\"uri\">www.clinicaltrials.gov<\/jats:ext-link>\n                      (registration number:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03026049\">NCT03026049<\/jats:ext-link>\n                      ) on 17 January 2017.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-017233","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T05:17:54Z","timestamp":1511241474000},"page":"e017233","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["A randomised controlled trial comparing venous stenting with conservative treatment in patients with deep venous obstruction: research protocol"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct03026049","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03026049","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Timme MAJ","family":"van Vuuren","sequence":"first","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands"},{"name":"Vascular surgery, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, Limburg, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorinde H H","family":"van Laanen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike","family":"de Geus","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands"},{"name":"Vascular surgery, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, Limburg, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty J","family":"Nelemans","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"de Graaf","sequence":"additional","affiliation":[{"name":"Department of Radiology, Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees H A","family":"Wittens","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands"},{"name":"Vascular surgery, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, Limburg, The Netherlands"},{"name":"Department of Vascular Surgery, University Hospital RWTH Aachen, Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"2025121600201531000_7.9.e017233.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.08.048"},{"key":"2025121600201531000_7.9.e017233.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00565.x"},{"key":"2025121600201531000_7.9.e017233.3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-9560-12-6","article-title":"Incidence of venous thromboembolism in northern Sweden (VEINS): a population-based study","volume":"12","author":"Johansson","year":"2014","journal-title":"Thromb J"},{"key":"2025121600201531000_7.9.e017233.4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410240085010"},{"key":"2025121600201531000_7.9.e017233.5","first-page":"169","article-title":"Factors influencing the recanalisation rate of deep venous thrombosis","volume":"31","author":"Jezovnik","year":"2012","journal-title":"International angiology: a journal of the International Union of Angiology"},{"key":"2025121600201531000_7.9.e017233.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-821X(05)80037-4"},{"key":"2025121600201531000_7.9.e017233.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-5884(97)80286-9"},{"key":"2025121600201531000_7.9.e017233.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03002.x"},{"key":"2025121600201531000_7.9.e017233.9","doi-asserted-by":"crossref","unstructured":"Rabinovich A , Kahn SR . The postthrombotic syndrome: current evidence and future challenges. JTH 2016.","DOI":"10.1007\/978-3-642-37078-6_129"},{"key":"2025121600201531000_7.9.e017233.10","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s00261-016-0793-9","article-title":"May-Thurner syndrome: MDCT findings and clinical correlates","volume":"41","author":"Lugo-Fagundo","year":"2016","journal-title":"Abdom Radiol"},{"key":"2025121600201531000_7.9.e017233.11","first-page":"912","article-title":"A vascular spur in the vena iliaca communis sinistra as a cause of predominantly left-sided thrombosis of the pelvic veins]","volume":"45","author":"May","year":"1956","journal-title":"Zeitschrift fur Kreislaufforschung"},{"key":"2025121600201531000_7.9.e017233.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.026"},{"key":"2025121600201531000_7.9.e017233.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2010.08.050"},{"key":"2025121600201531000_7.9.e017233.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2015.09.002"},{"key":"2025121600201531000_7.9.e017233.15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.21037\/qims.2016.07.07","article-title":"Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement","volume":"6","author":"Falcoz","year":"2016","journal-title":"Quant Imaging Med Surg"},{"key":"2025121600201531000_7.9.e017233.16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002772","article-title":"Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis","volume":"8","author":"Razavi","year":"2015","journal-title":"Circulation Cardiovascular interventions"},{"key":"2025121600201531000_7.9.e017233.17","doi-asserted-by":"publisher","DOI":"10.1177\/0268355515596474"},{"key":"2025121600201531000_7.9.e017233.18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.semvascsurg.2015.07.001","article-title":"Treatment of iliac-caval outflow obstruction","volume":"28","author":"Raju","year":"2015","journal-title":"Semin Vasc Surg"},{"key":"2025121600201531000_7.9.e017233.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2007.06.046"},{"key":"2025121600201531000_7.9.e017233.20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejvs.2015.02.007","article-title":"Editor's choice - management of chronic venous disease: clinical practice guidelines of the european society for vascular surgery (ESVS)","volume":"49","author":"Wittens","year":"2015","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery"},{"key":"2025121600201531000_7.9.e017233.21","first-page":"889","article-title":"CIRSE standards of practice guidelines on iliocaval stenting","volume":"37","author":"Mahnken","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2025121600201531000_7.9.e017233.22","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.10.1173"},{"key":"2025121600201531000_7.9.e017233.23","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-02-0152"},{"key":"2025121600201531000_7.9.e017233.24","doi-asserted-by":"publisher","DOI":"10.1136\/jech.53.1.46"},{"key":"2025121600201531000_7.9.e017233.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-014-0704-x"},{"key":"2025121600201531000_7.9.e017233.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.10.016"},{"key":"2025121600201531000_7.9.e017233.27","first-page":"8","article-title":"Validation of the Villalta scale in assessing post-thrombotic syndrome using clinical, duplex, and hemodynamic comparators","volume":"2","author":"Lattimer","year":"2014","journal-title":"J Vasc Surg"},{"key":"2025121600201531000_7.9.e017233.28","doi-asserted-by":"crossref","unstructured":"Hameed M , Onida S , Davies AH . What is pathological May-Thurner syndrome? Phlebology 2016.","DOI":"10.1177\/0268355516680458"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-017233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:20:28Z","timestamp":1765873228000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-017233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,11]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1136\/bmjopen-2017-017233"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-017233","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}